Research
In-depth company research, stock analysis, and market opportunities from the Smart Investors Daily research team.
# CDE: InnoCare’s IND Approval Sparks Mining Surge! ## Introduction Coeur Mining, Inc. (NYSE: CDE) – a U.S.-based gold and silver miner – has seen its stock surge amid improving…
Read more# ROIV: Enrollment Complete for Phase 2 PHocus Study!
Read more# TGTX: Major Data Presentation for BRIUMVI® This Week! ## Introduction **TG Therapeutics (NASDAQ: TGTX)** is a commercial-stage biotech focused on B-cell mediated diseases, most…
Read more# NWSA: Morgan Stanley Cuts Price Target to $32.40! ## Company Overview & Recent Developments News Corp (NASDAQ: **NWSA**), the company behind the Wall Street Journal,…
Read more# MU: Analysts Shock Market with Micron's Historic Call! ## Historic Rally and Surprising Analyst Upgrades Micron Technology (NASDAQ: **MU**) has stunned investors with a meteoric…
Read more# C: Ocular Therapeutix™ Inducement Grant Sparks Opportunity ## Overview – Inducement Grants as a Strategic Catalyst Ocular Therapeutix (NASDAQ: **OCUL**) has recently used…
Read more# MNDY: Piper Sandler Lowers Price Target, Still Overweight!
Read more# HAL: India's Fighter Jet Challenge Could Skyrocket Profits! ## Introduction Hindustan Aeronautics Limited (HAL) is India’s flagship aerospace and defense company, playing a…
Read more# Rosenblatt's Take: DDOG Still Poised for Growth Ahead! ## Dividend Policy and Cash Flow Datadog **does not pay any dividend**, instead reinvesting all earnings for growth.
Read more# Bath & Body Works (BBWI) – Company Overview Bath & Body Works, Inc. (NYSE: BBWI) is a specialty retailer of personal care and home fragrance products, operating **~1,800…
Read more# IMVT: Corporate Updates & Q3 Results You Can't Miss! **Company Overview:** Immunovant, Inc.
Read more# TGTX: New Data on BRIUMVI® Could Shift MS Treatment! ## Overview of TG Therapeutics (TGTX) **TG Therapeutics, Inc. (NASDAQ: TGTX)** is a commercial-stage biotech company focused…
Read moreClass Action & Trial Failure – Investor Fallout: Mereo BioPharma (NASDAQ: MREO) is facing intense scrutiny after a late-2025 shock that wiped out nearly 88% of its stock value and…
Read more# IDR Surges: Fitch Boosts Iceland to ‘A+’ Rating!
Read moreNFLX Under Investigation: What This Means for Your Portfolio Introduction: Netflix (NASDAQ: NFLX) is the world’s leading streaming entertainment service with over 260 million paid…
Read more# **C: Citigroup’s Strategic Move Sparks Market Opportunity!** ## **Introduction** Citigroup Inc. (NYSE: C) is undergoing a strategic overhaul under CEO Jane Fraser, aiming to…
Read more# ROIV: Pulmovant Completes Phase 2 Enrollment—What’s Next?
Read more# WGO's $100M Note Redemption: A Game Changer Ahead!
Read more# MPC: RBI Meeting Live—Rate Cut or Hold? Don’t Miss Out! ## Dividend Policy & Yield History Marathon Petroleum Corp.
Read more# H: Don't miss Manchester City's exclusive ticket drop!
Read more
